Evidence map›Paper›PMID 33320107›Full record

ReviewEndocrine connections2021

Hormonal control of cardiac regenerative potential.

Alexander V Amram, Stephen Cutie, Guo N Huang

Open access · goldAbstract readReview
In one paragraph

Review in Endocrine connections, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Review
  3. Inter-organ communication during tissue regeneration.Development (Cambridge, England) · 2023
    Review
  4. Article
  5. Unlocking cardiomyocyte renewal potential for myocardial regeneration therapy.Journal of molecular and cellular cardiology · 2023
    Review
  6. Review
  7. Transient reprogramming primes the heart for repair.The journal of cardiovascular aging · 2022
    Article
  8. Innate Mechanisms of Heart Regeneration.Cold Spring Harbor perspectives in biology · 2021
    Review
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Alexander V AmramDepartment of Physiology, Cardiovascular Research Institute, University of California, San Francisco, San Francisco, California, USA.
Stephen CutieDepartment of Physiology, Cardiovascular Research Institute, University of California, San Francisco, San Francisco, California, USA.
Guo N HuangDepartment of Physiology, Cardiovascular Research Institute, University of California, San Francisco, San Francisco, California, USA.ORCID 0000-0002-4335-9123
University of California, San Francisco · USBroad Center · US

Funding

Molecular control of cardiac regenerative potentialR01HL138456 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Guo Huang · 2018 to 2026
$5.1M
Elucidating the endocrine regulation of cardiac regeneration in vertebratesF31HL145935 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CUTIE, STEPHEN · 2019 to 2021
$85k
NHLBI NIH HHS F31 HL145935NHLBI NIH HHS R01 HL138456
6 · The paper itself

Abstract

Research conducted across phylogeny on cardiac regenerative responses following heart injury implicates endocrine signaling as a pivotal regulator of both cardiomyocyte proliferation and heart regeneration. Three prominently studied endocrine factors are thyroid hormone, vitamin D, and glucocorticoids, which canonically regulate gene expression through their respective nuclear receptors thyroid hormone receptor, vitamin D receptor, and glucocorticoid receptor. The main animal model systems of interest include humans, mice, and zebrafish, which vary in cardiac regenerative responses possibly due to the differential onsets and intensities of endocrine signaling levels throughout their embryonic to postnatal organismal development. Zebrafish and lower vertebrates tend to retain robust cardiac regenerative capacity into adulthood while mice and other higher vertebrates experience greatly diminished cardiac regenerative potential in their initial postnatal period that is sustained throughout adulthood. Here, we review recent progress in understanding how these three endocrine signaling pathways regulate cardiomyocyte proliferation and heart regeneration with a particular focus on the controversial findings that may arise from different assays, cellular-context, age, and species. Further investigating the role of each endocrine nuclear receptor in cardiac regeneration from an evolutionary perspective enables comparative studies between species in hopes of extrapolating the findings to novel therapies for human cardiovascular disease.

Indexed as

cardiomyocyte proliferationglucocorticoidsheart regenerationthyroid hormonesvitamin D

Identifiers

PMID33320107
PMCPMC7923045
OpenAlexW3110789305

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.